ClinicalTrials.Veeva

Find clinical trials for Prostate Cancer in New York, NY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Recurrence
Adenocarcinoma
Breast Cancer

Prostate Cancer trials near New York, NY, USA:

MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer

biopsy alone in diagnosing subjects with clinically significant prostate cancer with MRI visible lesions. This study will consist o...

Enrolling
Elevated Prostate Specific Antigen
Prostate Disease
Device: MR/TRUS Fusion Guided Prostate Biopsy
Other: MR US Fusion Guided Prostate Biopsy
Ardeshir Rastinehad

New York, New York, United States and 2 other locations

therapy in participants with metastatic castration-resistant prostate cancer (mCRPC) comprising 2 phases: a Phase 1 Dose Escalation...

Enrolling
Prostate Cancer Metastatic
Biological: HB-302/HB-301 Alternating 2-Vector Therapy

Phase 1, Phase 2

Hookipa Biotech

New York, New York, United States and 9 other locations

and docetaxel in patients with newly metastatic, hormone-sensitive prostate cancer (mHSPC), using a primary endpoint of undetectabl...

Active, not recruiting
Prostate Cancer Metastatic
Drug: Leuprolide Acetate
Drug: Degarelix

Phase 2

Mark Stein

New York, New York, United States

the UroNav software and DynaCAD software for planning and treating prostate cancer as an add on to the already approved workflow of...

Enrolling
Prostate Disease
Prostate Cancer
Device: Cryo-ablation Using DynaCAD / UroNAV preplanning / guidance
Northwell Health
Northwell Health

New York, New York, United States and 2 other locations

study is a randomized study that compares 5 radiation therapy treatments to 2 radiation therapy treatments in men with low or intermediate-risk prostate...

Enrolling
Prostate Cancer
Radiation: Radiation Therapy

Phase 2

Weill Cornell Medicine (WCM)
Weill Cornell Medicine (WCM)

New York, New York, United States and 1 other location

of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...

Enrolling
Metastatic Prostate Cancer
Biological: AZD0754

Phase 1, Phase 2

AstraZeneca
AstraZeneca

New York, New York, United States and 7 other locations

A Phase 1/2a, open-label, multicenter study of intramuscular (i.m.) PRL-02 depot in participants with advanced prostate cancer....

Enrolling
Prostate Cancer
mCSPC
Drug: prednisone
Drug: dexamethasone

Phase 1, Phase 2

Propella Therapeutics

Morristown, New Jersey, United States and 13 other locations

androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...

Active, not recruiting
Prostate Cancer
Drug: Placebo oral tablet
Drug: Luteinizing Hormone-Releasing Hormone Analog

Phase 3

University of Sydney

New York, New York, United States and 92 other locations

The purpose of this trial is to investigate the safety and tolerability of TAS3681, to find the maximum tolerated dose (MTD)/recommended dose of TAS3...

Active, not recruiting
Metastatic Castration Resistant Prostate Cancer
Drug: TAS3681

Phase 1

Taiho Pharma
Taiho Pharma

New York, New York, United States and 33 other locations

pharmacodynamic (PD), and the preliminary efficacy of JANX007 administered as a single agent in adults with metastatic castration-resistant prostate...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007

Phase 1

Janux Therapeutics

New York, New York, United States and 10 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems